Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd researches, develops, produces, and sells Chinese medicines, health food, and APIs. It offers Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, and Astragalus Angelica capsules, as well as berberine tannin films. The company also engages in the planting, acquisition, processing, sales, and commercial distribution of Chinese medicinal materials; investment and management of project; and import, sales, logistics, and export of pharmaceutical. Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd was founded in 2002 and is based in Lanzhou, China.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued